X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (40) 40
male (35) 35
neurosciences (29) 29
humans (26) 26
neurology (24) 24
female (23) 23
middle aged (16) 16
aged (15) 15
aged, 80 and over (14) 14
animals (13) 13
time factors (13) 13
brain (12) 12
cardiovascular (12) 12
ischemia (12) 12
rats (12) 12
clinical neurology (11) 11
peripheral vascular disease (11) 11
retrospective studies (11) 11
stroke (11) 11
tissue plasminogen activator (10) 10
dementia (9) 9
treatment outcome (9) 9
alzheimer's disease (8) 8
disease models, animal (8) 8
neurovascular unit (8) 8
stroke - drug therapy (8) 8
adult (7) 7
medicine, general & internal (7) 7
rats, wistar (7) 7
brain ischemia - drug therapy (6) 6
care and treatment (6) 6
diagnosis (6) 6
fibrinolytic agents - therapeutic use (6) 6
hypertension (6) 6
neuropsychological tests (6) 6
rats, inbred shr (6) 6
tissue plasminogen activator - adverse effects (6) 6
activities of daily living (5) 5
blood-pressure (5) 5
edaravone (5) 5
fibrinolytic agents - adverse effects (5) 5
japan (5) 5
matrix metalloproteinase 9 - metabolism (5) 5
reperfusion (5) 5
thrombolysis (5) 5
tissue plasminogen activator - therapeutic use (5) 5
tissue-plasminogen activator (5) 5
tpa (5) 5
warfarin (5) 5
alteplase (4) 4
angiotensin ii type 1 receptor blockers - pharmacology (4) 4
benzimidazoles - pharmacology (4) 4
benzoates - pharmacology (4) 4
case report (4) 4
cerebral cortex - drug effects (4) 4
cerebral cortex - metabolism (4) 4
cognition - physiology (4) 4
cognitive function (4) 4
dose-response relationship, drug (4) 4
follow-up studies (4) 4
free-radical scavenger (4) 4
glial fibrillary acidic protein - metabolism (4) 4
intracerebral hemorrhage (4) 4
ischemic stroke (4) 4
japan - epidemiology (4) 4
magnetic resonance imaging (4) 4
medical colleges (4) 4
model (4) 4
neurology. diseases of the nervous system (4) 4
oxidative stress (4) 4
psychiatric status rating scales (4) 4
risk factors (4) 4
severity of illness index (4) 4
telmisartan (4) 4
thrombolytic therapy - adverse effects (4) 4
acute ischemic stroke (3) 3
affective disorder (3) 3
affective function (3) 3
alzheimer disease - drug therapy (3) 3
alzheimers-disease (3) 3
angiotensin (3) 3
antipyrine - analogs & derivatives (3) 3
association (3) 3
atrophy (3) 3
brain - drug effects (3) 3
brain - pathology (3) 3
cardiology (3) 3
cerebrospinal fluid (3) 3
cognition disorders - diagnosis (3) 3
depression (3) 3
diagnosis, differential (3) 3
diffusion magnetic resonance imaging (3) 3
disease (3) 3
donepezil (3) 3
expression (3) 3
fibrinolytic agents - administration & dosage (3) 3
focal cerebral-ischemia (3) 3
guidelines (3) 3
impairment (3) 3
incidence (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal of Neuroscience Research, ISSN 0360-4012, 09/2017, Volume 95, Issue 9, pp. 1818 - 1828
Journal Article
Journal Article
Journal of Neuroscience Research, ISSN 0360-4012, 03/2014, Volume 92, Issue 3, pp. 369 - 374
Journal Article
Journal Article
Journal of Stroke and Cerebrovascular Diseases, ISSN 1052-3057, 2016, Volume 26, Issue 4, pp. 899 - 899
Journal Article
Journal of Stroke and Cerebrovascular Diseases, ISSN 1052-3057, 04/2017, Volume 26, Issue 4, pp. 899 - 899
Journal Article
Journal Article
Journal of Neuroscience Research, ISSN 0360-4012, 10/2014, Volume 92, Issue 10, pp. 1330 - 1337
Journal Article
Stroke, ISSN 0039-2499, 08/2014, Volume 45, Issue 8, pp. 2404 - 2410
Journal Article
Journal of Stroke and Cerebrovascular Diseases, ISSN 1052-3057, 2015, Volume 24, Issue 3, pp. 537 - 547
Telmisartan is a highly lipid-soluble angiotensin receptor blocker (ARB), which improves insulin sensitivity and reduces triglyceride levels and, thus, is... 
Neurology | Cardiovascular | Spontaneously hypertensive rat | telmisartan | Alzheimer disease | inflammasome | neurovascular unit | OXIDATIVE STRESS | FOCAL CEREBRAL-ISCHEMIA | NEURONAL INJURY | ANGIOTENSIN-II | NEUROSCIENCES | RECEPTOR ANTAGONIST | BLOOD-PRESSURE | MATRIX METALLOPROTEINASES | ENDOTHELIAL-CELLS | PPAR-GAMMA | PERIPHERAL VASCULAR DISEASE | CANDESARTAN | Encephalitis - prevention & control | Antihypertensive Agents - pharmacology | Inflammasomes - metabolism | NLR Family, Pyrin Domain-Containing 3 Protein | Cerebral Cortex - pathology | Hypertension - drug therapy | Male | Glial Fibrillary Acidic Protein - metabolism | Infarction, Middle Cerebral Artery - metabolism | Angiotensin II Type 1 Receptor Blockers - pharmacology | Cerebral Cortex - metabolism | Acetylglucosamine - metabolism | Matrix Metalloproteinase 9 - metabolism | Neuroprotective Agents - pharmacology | Time Factors | Infarction, Middle Cerebral Artery - complications | Encephalitis - metabolism | Blood Pressure - drug effects | Infarction, Middle Cerebral Artery - drug therapy | Cerebral Cortex - drug effects | Hypertension - diagnosis | Disease Models, Animal | Collagen Type IV - metabolism | Rats, Inbred SHR | Anti-Inflammatory Agents - pharmacology | Encephalitis - pathology | Infarction, Middle Cerebral Artery - pathology | Hypertension - physiopathology | Animals | Carrier Proteins - metabolism | Benzoates - pharmacology | Hypertension - complications | Benzimidazoles - pharmacology | Encephalitis - etiology | Stroke (Disease) | Hypertension | Brain | Ischemia | Collagen | Angiotensin | Intermediate filament proteins | Medical colleges | Neurons | Alzheimer's disease | Index Medicus
Journal Article